share_log

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 22 16:03
Summary by Moomoo AI
CRISPR Therapeutics officer Phuong Khanh Morrow is set to sell 50,767 shares of the company's common stock on 03/22/2024, as per the latest filings. The shares, valued at approximately $3,699,269.45, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment to the issuer for the securities. This sale comes without any reported transactions by Morrow in the past three months.
CRISPR Therapeutics officer Phuong Khanh Morrow is set to sell 50,767 shares of the company's common stock on 03/22/2024, as per the latest filings. The shares, valued at approximately $3,699,269.45, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment to the issuer for the securities. This sale comes without any reported transactions by Morrow in the past three months.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more